Neuropsychopharmacology
- Prevention of late-life depression: a framework and prospectus for research4 months ago
- Hair cortisol concentrations as a putative biomarker for suicidal behavior4 months ago
- Effects of electroconvulsive shock on the function, circuitry, and transcriptome of dentate gyrus granule neurons4 months ago
- Hypocretin receptor 1 blockade early in abstinence prevents incubation of cocaine seeking and normalizes dopamine transmission4 months ago
- Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [11C]UCB-J positron emission tomography study4 months ago
- Stereoselective, sex-dependent 5-HT2A receptor modulation of cortical plasticity by MDMA in mice4 months ago
- Medial prefrontal-thalamic white matter microstructure is associated with harm avoidance in OCD: a discovery and transdiagnostic replication study4 months ago
Journal of Psychopharmacology
- Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations7 months ago
- The effects of naturalistic cannabis use on cognition and subjective experience in older adults with normal cognitive function7 months ago
- A one-compartment model provides benchmark Lithium dose prediction7 months ago
- The phytocannabinoid cannabidivarin alleviates cognitive and social behaviour deficits in the sub-chronic phencyclidine rat model of relevance for schizophrenia7 months ago
- Pharmacological effects on 35% CO2 panic induction: A meta-analysis7 months ago
- Differential metabolism of citalopram by 21 CYP3A4 variants: An in vitro experiment7 months ago
- Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference?7 months ago
European Neuropsychopharmacology
- Activating β2-adrenergic receptor is a potential cross-disease therapeutic strategy for Alzheimer’s disease, obesity and type 2 diabetes6 months ago
- Patterns, predictors and outcomes of trajectories for subjective quality of life in patients with early psychosis: 12-year follow-up of the randomized controlled trial on extended early intervention6 months ago
- Persistent mortality gap in schizophrenia: current challenges and future directions6 months ago
- Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis7 months ago
- Chronic stress and brain kynurenine pathway: addressing unresolved issues with a meta-analytic approach of preclinical studies, translational implication for psychiatric disorders7 months ago
- Commentary on the article “Efficacy of pharmacogenetic-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis”7 months ago
- A call for more robust and interpretable models in predicting treatment-resistant depression7 months ago